Thomas R. Berry
FDA investigator
Appears on 1 document from 2010, mostly at sites in North Carolina. Most often cites sampling and testing of in-process materials and drug products (21 CFR 211.110(a)).
- 1
- Documents on file
- 6.0
- Observations per 483
- 2010
- First seen
- 2010
- Most recent
What they cite most
From 6 observations- 21 CFR 211.110(a)Sampling and testing of in-process materials and drug products2
- 21 CFR 820.70(a)Production and process controls2
- 21 CFR 820.100(a)(6)Corrective and preventive action1
- 21 CFR 820.75(a)Process validation1
Activity by year
2010: 1
Where
North Carolina 1
Is Thomas R. Berry coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2010-01-19 | 483 Hospira, Inc.Jan 19, 2010 · Rocky Mount, North Carolina | Rocky Mount, North Carolina | 6 |
About this profile
What does Thomas R. Berry inspect?
Thomas R. Berry appears on 1 document on file covering 1 site, mostly in North Carolina.
What do they cite most often?
21 CFR 211.110(a) (sampling and testing of in-process materials and drug products), followed by 21 CFR 820.70(a) and 21 CFR 820.100(a)(6).
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Thomas R. Berry is dated Jan 19, 2010.